Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

NCT04649515 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Low recruitment rate

Conditions

Interventions

Sponsor

Tychan Pte Ltd.